Tofacitinib Tablets 5mg Tofajak
Manufacturer: Cipla INDIA LTD
What is the purpose of Tofacitinib Tablets 5mg Tofajak?
Tofacitinib Tablets 5mg Tofajak is used alone or in combination with other medications to treat adults with rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function). These patients are either unable to take one or more tumour necrosis factor (TNF) inhibitor medications or did not respond to them (s).
What is the purpose of tofacitinib?
Patients who have previously taken other medications can use tofacitinib alone or in combination with other medications (such as DMARDs) to treat moderately to severely active rheumatoid arthritis, active psoriatic Juvenile idiopathic polyarticular course arthritis, ulcerative colitis, ankylosing spondylitis (pcJIA).
Tofacitinib – is it a steroid?
This prospective, open-label proof-of-concept experiment is investigating tofacitinib, a Janus kinase inhibitor, as a steroid-free therapy for corticosteroid-dependent pulmonary sarcoidosis.
What potential side effects could Tofacitinib Tablets 5mg Tofajak, have?
- Upper respiratory tract infections, headaches
- diarrhoea, and nasopharyngitis are among Tofajak 5mg Tablet’s most frequent adverse effects.
- Blood clots
- stomach or intestinal wall rips, and other less frequent but more severe side effects are also possible.
- These require immediate medical care.
To know more Click here
How long is Tofacitinib Tablets 5mg Tofajak safe to take?
Tofacitinib is an ongoing medication.Within the first 12 weeks of starting the regimen, the vast majority of patients who benefit from this medication will notice improvement.
Tofacitinib Tablets 5mg Tofajak Is it safe?
Our research has shown that arthritis and ulcerative colitis increase the risk of serious heart-related events such heart attack or stroke, cancer, blood clots, and mortality. medications based on a finished FDA analysis of a sizable randomised safety research trial. both Xeljanz
Does Tofacitinib Tablets 5mg Tofajak result in hair thinning?
Official response. The results of the clinical trials necessary to have the drug approved reveal that the active ingredient in Xeljanz, tofacitinib citrate, does not cause hair loss. Hair loss was not a side effect that was noted during clinical development.
Is Tofacitinib Tablets 5mg Tofajak an anaesthetic?
It helps to lessen edoema, sensitivity, and joint pain. Tofacitinib is also used to treat a specific intestinal disease (ulcerative colitis). It helps to relieve the symptoms of ulcerative colitis, such as abdominal pain, rectal bleeding, and diarrhoea.
How well does tofacitinib work?
Effectiveness (4.1). Tofacitinib significantly decreased disease activity in the patient population, resulting in 58.2% of patients achieving LDA and 49.5% achieving remission at follow-up. This is a little higher than in phase I–III clinical trials that have been reported.
I’m on tofacitinib; when should I stop?
Patients who have had a stroke or a myocardial infarction should stop using tofacitinib. Thrombosis: Patients receiving tofacitinib and other Janus kinase inhibitors used to treat inflammatory disorders have experienced thrombosis, including pulmonary embolism, deep vein thrombosis, and arterial thrombosis.
We are a regular distributor, a supplier based in India, and an exporter with operations in more than five foreign countries, including the Oman, South Africa, Qatar, Egypt, USA, etc. In the unlikely occasion if you’re looking for a product or brand, Click here.